{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T11:38:27Z","timestamp":1792669107492,"version":"4.5.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Diabetes and its Complications"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.jdiacomp.2012.05.005","type":"journal-article","created":{"date-parts":[[2012,6,13]],"date-time":"2012-06-13T06:49:44Z","timestamp":1339570184000},"page":"435-441","source":"Crossref","is-referenced-by-count":62,"title":["Imbalanced levels of angiogenic and angiostatic factors in vitreous, plasma and postmortem retinal tissue of patients with proliferative diabetic retinopathy"],"prefix":"10.1016","volume":"26","author":[{"given":"Nithyakalyani","family":"Mohan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Finny","family":"Monickaraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muthuswamy","family":"Balasubramanyam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohan","family":"Rema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viswanathan","family":"Mohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdiacomp.2012.05.005_bb0005","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1001\/archophthalmol.2009.355","article-title":"Association between erythropoietin gene polymorphisms and diabetic retinopathy","volume":"128","author":"Abhary","year":"2010","journal-title":"Archives of Ophthalmology"},{"key":"10.1016\/j.jdiacomp.2012.05.005_bb0010","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1056\/NEJM199412013312203","article-title":"Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders","volume":"331","author":"Aiello","year":"1994","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.jdiacomp.2012.05.005_bb0015","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.2337\/diabetes.46.9.1473","article-title":"Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective B-isoform-selective inhibitor","volume":"46","author":"Aiello","year":"1997","journal-title":"Diabetes"},{"key":"10.1016\/j.jdiacomp.2012.05.005_bb0020","doi-asserted-by":"crossref","first-page":"10457","DOI":"10.1073\/pnas.92.23.10457","article-title":"Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins","volume":"92","author":"Aiello","year":"1995","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.jdiacomp.2012.05.005_bb0025","doi-asserted-by":"crossref","first-page":"3974","DOI":"10.1073\/pnas.91.9.3974","article-title":"Erythropoietin receptor mRNA expression in human endothelial cells","volume":"91","author":"Anagnostou","year":"1994","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.jdiacomp.2012.05.005_bb0030","doi-asserted-by":"crossref","first-page":"240","DOI":"10.3109\/08820539909069543","article-title":"Molecular mechanisms of vascular permeability in diabetic retinopathy","volume":"14","author":"Antonetti","year":"1999","journal-title":"Seminars in Ophthalmology"},{"key":"10.1016\/j.jdiacomp.2012.05.005_bb0035","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1203\/00006450-200204000-00012","article-title":"Erythropoietin stimulates vasculogenesis in neonatal rat mesenteric microvascular endothelial cells","volume":"51","author":"Ashley","year":"2002","journal-title":"Pediatric Research"},{"key":"10.1016\/j.jdiacomp.2012.05.005_bb0040","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0002-9394(57)90426-9","article-title":"Retinal vascularization in health and disease","volume":"44","author":"Ashton","year":"1957","journal-title":"American Journal of Ophthalmology"},{"key":"10.1016\/j.jdiacomp.2012.05.005_bb0045","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/j.ophtha.2006.05.064","article-title":"Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy","volume":"113","author":"Avery","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jdiacomp.2012.05.005_bb0050","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/sj.gt.3301680","article-title":"Inhibition of retinal neovascularisation by gene transfer of soluble VEGF receptor sFlt-1","volume":"9","author":"Bainbridge","year":"2002","journal-title":"Gene Therapy"},{"key":"10.1016\/j.jdiacomp.2012.05.005_bb0055","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/0014-4835(89)90064-X","article-title":"Opposing effects of basic fibroblast growth factor and transforming growth factor-, on the proliferation of cultured bovine retinal capillary endothelial cells (BREC)","volume":"48","author":"Bensaid","year":"1989","journal-title":"Experimental Eye Research"},{"key":"10.1016\/j.jdiacomp.2012.05.005_bb0060","first-page":"596","article-title":"Angiogenic activity of vitreous and retinal extract","volume":"19","author":"Chen","year":"1980","journal-title":"Investigative Ophthalmology and Visual Science"},{"key":"10.1016\/j.jdiacomp.2012.05.005_bb0065","first-page":"526","article-title":"Erythropoietin deficiency decreases vascular stability in mice","volume":"118","author":"Chen","year":"2008","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.jdiacomp.2012.05.005_bb0070","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0165-3806(01)00220-6","article-title":"Astrocyte-derived VEGF mediates survival and tube stabilization of hypoxic brain microvascular endothelial cells in vitro","volume":"130","author":"Chow","year":"2001","journal-title":"Brain Research. Developmental Brain Research"},{"key":"10.1016\/j.jdiacomp.2012.05.005_bb0075","doi-asserted-by":"crossref","first-page":"14524","DOI":"10.1021\/bi0265022","article-title":"Glycosylation of erythropoietin affects receptor binding kinetics: role of electrostatic interactions","volume":"10","author":"Darling","year":"2002","journal-title":"Biochemistry"},{"key":"10.1016\/j.jdiacomp.2012.05.005_bb0080","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1126\/science.285.5425.245","article-title":"Pigment epithelium-derived factor: a potent inhibitor of angiogenesis","volume":"285","author":"Dawson","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.jdiacomp.2012.05.005_bb0085","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/BF03402029","article-title":"Erythropoietin therapy for acute stroke is both safe and beneficial","volume":"8","author":"Ehrenreich","year":"2002","journal-title":"Molecular Medicine"},{"key":"10.1016\/j.jdiacomp.2012.05.005_bb0090","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/0272-6386(95)90175-2","article-title":"Erythropoietin in diabetic macular edema and renal insufficiency","volume":"26","author":"Friedman","year":"1995","journal-title":"American Journal of Kidney Diseases"},{"key":"10.1016\/j.jdiacomp.2012.05.005_bb0095","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S0014-5793(01)02110-X","article-title":"Unbalanced expression of VEGF and PEDF in ischemia-induced retinal neovascularization","volume":"489","author":"Gao","year":"2001","journal-title":"FEBS Letters"},{"key":"10.1016\/j.jdiacomp.2012.05.005_bb0100","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.2337\/dc07-2075","article-title":"Expression of erythropoietin and its receptor in the human retina: a comparative study of diabetic and nondiabetic subjects","volume":"31","author":"Garc\u00eda-Ram\u00edrez","year":"2008","journal-title":"Diabetes Care"},{"issue":"Suppl. 1","key":"10.1016\/j.jdiacomp.2012.05.005_bb0105","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1159\/000080705","article-title":"Can erythropoietin therapy improve survival?","volume":"67","author":"Glaspy","year":"2004","journal-title":"Oncology"},{"key":"10.1016\/j.jdiacomp.2012.05.005_bb0110","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1083\/jcb.84.2.298","article-title":"Demonstration of vasoproliferative activity from mammalian retina","volume":"84","author":"Glazer","year":"1980","journal-title":"The Journal of Cell Biology"},{"key":"10.1016\/j.jdiacomp.2012.05.005_bb0115","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/nm723","article-title":"HIF-1-induced erythropoietin in the hypoxic retina protects against light-induced retinal degeneration","volume":"8","author":"Grimm","year":"2002","journal-title":"Nature Medicine"},{"key":"10.1016\/j.jdiacomp.2012.05.005_bb0120","doi-asserted-by":"crossref","first-page":"39748","DOI":"10.1074\/jbc.M101117200","article-title":"Vascular endothelial growth factor 165 (VEGF(165)) activities are inhibited by carboxymethyl benzylamide dextran that competes for heparin binding to VEGF(165) and VEGF(165).KDR complexes","volume":"276","author":"Hamma-Kourbali","year":"2001","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.jdiacomp.2012.05.005_bb0125","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.2337\/dc06-0556","article-title":"Erythropoietin is expressed in the human retina and it is highly elevated in the vitreous fluid of patients with diabetic macular edema","volume":"29","author":"Hern\u00e1ndez","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2012.05.005_bb0130","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0002-9394(02)01549-0","article-title":"Pigment epithelium derived factor is deficient in the vitreous of patients with choroidal neovascularization due to age-related macular degeneration","volume":"134","author":"Holekamp","year":"2002","journal-title":"American Journal of Ophthalmology"},{"key":"10.1016\/j.jdiacomp.2012.05.005_bb0135","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1097\/00001756-200404090-00029","article-title":"Elevated erythropoietin in vitreous with ischemic retinal diseases","volume":"9","author":"Inomata","year":"2004","journal-title":"NeuroReport"},{"key":"10.1016\/j.jdiacomp.2012.05.005_bb0140","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1152\/physrev.1992.72.2.449","article-title":"Erythropoietin: structure, control of production, and function","volume":"72","author":"Jelkmann","year":"1992","journal-title":"Physiological Reviews"},{"key":"10.1016\/j.jdiacomp.2012.05.005_bb0145","doi-asserted-by":"crossref","first-page":"10659","DOI":"10.1073\/pnas.152321399","article-title":"Erythropoietin administration protects retinal neurons from acute ischemia-reperfusion injury","volume":"99","author":"Junk","year":"2002","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.jdiacomp.2012.05.005_bb0150","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.2337\/diacare.28.9.2252","article-title":"Erythropoietin is highly elevated in vitreous fluid of patients with proliferative diabetic retinopathy","volume":"28","author":"Katsura","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2012.05.005_bb0155","first-page":"76","article-title":"Reversal of anemia by erythropoietin therapy retards the progression of chronic renal failure, especially in nondiabetic patients","volume":"77","author":"Kuriyama","year":"1997","journal-title":"Nephron"},{"key":"10.1016\/j.jdiacomp.2012.05.005_bb0160","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3109\/02713688608995160","article-title":"Presence of endothelial cell growth factor activity in normal and diabetic eyes","volume":"5","author":"Lutty","year":"1986","journal-title":"Current Eye Research"},{"key":"10.1016\/j.jdiacomp.2012.05.005_bb0165","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1001\/archopht.1996.01100140179011","article-title":"Localization of vascular endothelial growth factor in human retina and choroid","volume":"114","author":"Lutty","year":"1996","journal-title":"Archives of Ophthalmology"},{"key":"10.1016\/j.jdiacomp.2012.05.005_bb0170","first-page":"871","article-title":"Serum-induced proliferation of retinal capillary endothelial cells is inhibited in the presence of retinal extract","volume":"8","author":"McIntosh","year":"1989","journal-title":"Current Eye Research"},{"key":"10.1016\/j.jdiacomp.2012.05.005_bb0175","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.2337\/db11-0026","article-title":"Intervention with an erythropoietin-derived peptide protects against neuroglial and vascular degeneration during diabetic retinopathy","volume":"60","author":"McVicar","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.jdiacomp.2012.05.005_bb0180","first-page":"137","article-title":"The mode of development of the vascular system of the retina, with some observations on its significance for certain retinal diseases","volume":"65","author":"Michaelson","year":"1948","journal-title":"Transactions of the Ophthalmological Society of the United Kingdom"},{"key":"10.1016\/j.jdiacomp.2012.05.005_bb0185","first-page":"125","article-title":"Growth factors and diabetic retinopathy","volume":"23","author":"Paques","year":"1997","journal-title":"Diabetes & Metabolism"},{"key":"10.1016\/j.jdiacomp.2012.05.005_bb0190","first-page":"1133","article-title":"Studies on retinal neovascularization","volume":"19","author":"Patz","year":"1980","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"10.1016\/j.jdiacomp.2012.05.005_bb0195","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.2337\/diabetes.46.10.1619","article-title":"Regulation of vascular endothelial growth factor expression by insulin-like growth factor","volume":"46","author":"Punglia","year":"1997","journal-title":"Diabetes"},{"key":"10.1016\/j.jdiacomp.2012.05.005_bb0200","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/359843a0","article-title":"Vascular endothelial growth factor induced by hypoxia may mediate hypoxia initiated angiogenesis","volume":"359","author":"Scheiki","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.jdiacomp.2012.05.005_bb0205","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1126\/science.6823562","article-title":"Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid","volume":"219","author":"Senger","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.jdiacomp.2012.05.005_bb0210","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/S0002-9394(02)02149-9","article-title":"Treatment of anemia in the diabetic patient with retinopathy and kidney disease","volume":"135","author":"Sinclair","year":"2003","journal-title":"American Journal of Ophthalmology"},{"key":"10.1016\/j.jdiacomp.2012.05.005_bb0215","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.2337\/diabetes.50.12.2641","article-title":"Loss of antiangiogenic pigment epithelium-derived factor in patients with angiogenic eye disease","volume":"50","author":"Spranger","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.jdiacomp.2012.05.005_bb0220","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1073\/pnas.90.4.1526","article-title":"Pigment epithelium-derived factor: neurotrophic activity and identification as a member of the serine protease inhibitor gene family","volume":"90","author":"Steele","year":"1993","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.jdiacomp.2012.05.005_bb0225","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1073\/pnas.031252398","article-title":"Prevention of ischemia-induced retinopathy by the natural ocular antiangiogenic agent pigment epithelium-derived factor","volume":"98","author":"Stellmach","year":"2001","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.jdiacomp.2012.05.005_bb0230","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2174\/157339906775473671","article-title":"Angiogenic and antiangiogenic factors in proliferative diabetic retinopathy","volume":"2","author":"Sim\u00f3","year":"2006","journal-title":"Current Diabetes Reviews"},{"key":"10.1016\/j.jdiacomp.2012.05.005_bb0235","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1016\/S0161-6420(96)30420-X","article-title":"Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate","volume":"103","author":"Tolentino","year":"1996","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jdiacomp.2012.05.005_bb0240","doi-asserted-by":"crossref","first-page":"6998","DOI":"10.1073\/pnas.0800454105","article-title":"Promoter polymorphism of the erythropoietin gene in severe diabetic eye and kidney complications","volume":"105","author":"Tong","year":"2008","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.jdiacomp.2012.05.005_bb0245","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.mehy.2010.10.017","article-title":"Erythropoietin therapy for early diabetic retinopathy through its protective effects on retinal pericytes","volume":"76","author":"Wang","year":"2011","journal-title":"Medical Hypotheses"},{"key":"10.1016\/j.jdiacomp.2012.05.005_bb0250","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.mvr.2010.02.012","article-title":"Antiangiogenic effects and transcriptional regulation of pigment epithelium-derived factor in diabetic retinopathy","volume":"80","author":"Wang","year":"2010","journal-title":"Microvascular Research"},{"key":"10.1016\/j.jdiacomp.2012.05.005_bb0255","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1056\/NEJMoa041773","article-title":"Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy","volume":"353","author":"Watanabe","year":"2005","journal-title":"New England Journal of Medicine"}],"container-title":["Journal of Diabetes and its Complications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872712001213?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872712001213?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,29]],"date-time":"2019-06-29T23:08:44Z","timestamp":1561849724000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056872712001213"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":51,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S1056872712001213"],"URL":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2012.05.005","relation":{},"ISSN":["1056-8727"],"issn-type":[{"value":"1056-8727","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}